Meiji Seika Pharma establishes local subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan: Tokyo Friday, December 27, 2024, 13:00 Hrs [IST] Meiji Seika Pharma Co., Ltd., a pha ...

The drug and biotech sector had a turbulent year in 2024, starting strong but losing momentum in the second half. This ...

The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...

This phase can last months, requiring various protective measures to prevent complications. Graft-versus-host disease remains ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

“It is clear that NETs contribute to DED and this licensing agreement represents an important step in bringing our innovative treatments to patients who live with the daily challenges of DED,” said ...

New imaging technique able to identify early signs of graft-versus-host-disease in transplant patients. Read on!

Barclays PLC raised its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 143.4% during the 3rd quarter, according to the company in its most recent 13F filing with the ...

Incyte (NASDAQ:INCY – Get Free Report) had its price objective boosted by analysts at Wells Fargo & Company from $68.00 to ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

Plus: Next generation IVF, another successful pig-kidney transplant, worm secretions to treat inflammation, a new skin cancer ...

Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against ...